Filing Details
- Accession Number:
- 0001127602-18-033470
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-16 17:37:47
- Reporting Period:
- 2018-11-14
- Accepted Time:
- 2018-11-16 17:37:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1140859 | Amerisourcebergen Corp | ABC | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 233079390 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1412636 | G. John Chou | 1300 Morris Drive Chesterbrook PA 19087 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-15 | 6,974 | $37.37 | 58,426 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-11-15 | 6,974 | $88.51 | 51,452 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-11-15 | 4,642 | $0.00 | 56,094 | No | 4 | A | Direct | |
Common Stock | Disposition | 2018-11-15 | 2,019 | $92.22 | 54,075 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Acquisiton | 2018-11-14 | 33,877 | $89.58 | 33,877 | $89.58 |
Common Stock | Restricted Stock Units | Acquisiton | 2018-11-14 | 4,689 | $0.00 | 4,689 | $89.58 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
33,877 | 2025-11-14 | No | 4 | A | Direct | |
9,378 | 2025-11-14 | No | 4 | A | Direct |
Footnotes
- The exercise and sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan dated May 30, 2018.
- Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units.
- Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.
- Annual grant of restricted stock received for no consideration and vests 100% on the third anniversary of the date of grant
- Exercisable in four equal installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.